AREC — Arecor Therapeutics Share News
0.000.00%
- £23.98m
- £20.95m
- £5.05m
REG - Arecor Therapeutics - Unaudited Preliminary Results for 2022
AnnouncementREG - Arecor Therapeutics - Arecor Appoints Chief Business Officer
AnnouncementREG - Arecor Therapeutics - FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL
AnnouncementREG - Arecor Therapeutics - Price Monitoring Extension
AnnouncementREG - Arecor Therapeutics - Price Monitoring Extension
AnnouncementREG - Arecor Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Arecor Therapeutics - Price Monitoring Extension
AnnouncementREG - Arecor Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Arecor Therapeutics - Price Monitoring Extension
AnnouncementREG - Arecor Therapeutics - Second Price Monitoring Extn
AnnouncementRCS - Arecor Therapeutics - ARECOR TO PRESENT SHARESOC WEBINAR
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
AnnouncementREG - Arecor Therapeutics - Notice of Results
AnnouncementREG - Arecor Therapeutics - Arecor Granted Patents in India and the US
AnnouncementREG - Arecor Therapeutics - ARECOR STRENGTHENS COLLABORATION WITH PARTNER
AnnouncementRCS - Arecor Therapeutics - Arecor Publishes Data for AT278 in Diabetes Care
AnnouncementREG - Arecor Therapeutics - BUSINESS UPDATE
AnnouncementREG - Arecor Therapeutics - ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA
AnnouncementRCS - Arecor Therapeutics - TETRIS PHARMA LAUNCHES OGLUO® IN AUSTRIA
Announcement